Discrete spatio-temporal regulation of tyrosine phosphorylation directs influenza A virus M1 protein towards its function in virion assembly.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
24
01
2020
accepted:
02
07
2020
revised:
11
09
2020
pubmed:
1
9
2020
medline:
6
10
2020
entrez:
1
9
2020
Statut:
epublish
Résumé
Small RNA viruses only have a very limited coding capacity, thus most viral proteins have evolved to fulfill multiple functions. The highly conserved matrix protein 1 (M1) of influenza A viruses is a prime example for such a multifunctional protein, as it acts as a master regulator of virus replication whose different functions have to be tightly regulated. The underlying mechanisms, however, are still incompletely understood. Increasing evidence points towards an involvement of posttranslational modifications in the spatio-temporal regulation of M1 functions. Here, we analyzed the role of M1 tyrosine phosphorylation in genuine infection by using recombinant viruses expressing M1 phosphomutants. Presence of M1 Y132A led to significantly decreased viral replication compared to wildtype and M1 Y10F. Characterization of phosphorylation dynamics by mass spectrometry revealed the presence of Y132 phosphorylation in M1 incorporated into virions that is most likely mediated by membrane-associated Janus kinases late upon infection. Molecular dynamics simulations unraveled a potential phosphorylation-induced exposure of the positively charged linker domain between helices 4 and 5, supposably acting as interaction platform during viral assembly. Consistently, M1 Y132A showed a defect in lipid raft localization due to reduced interaction with viral HA protein resulting in a diminished structural stability of viral progeny and the formation of filamentous particles. Importantly, reduced M1-RNA binding affinity resulted in an inefficient viral genome incorporation and the production of non-infectious virions that interferes with virus pathogenicity in mice. This study advances our understanding of the importance of dynamic phosphorylation as a so far underestimated level of regulation of multifunctional viral proteins and emphasizes the potential feasibility of targeting posttranslational modifications of M1 as a novel antiviral intervention.
Identifiants
pubmed: 32866218
doi: 10.1371/journal.ppat.1008775
pii: PPATHOGENS-D-20-00137
pmc: PMC7485975
doi:
Substances chimiques
M1 protein, Influenza A virus
0
Viral Matrix Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1008775Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Virol. 2000 Dec;74(24):11538-47
pubmed: 11090151
Virology. 2001 Mar 1;281(1):102-8
pubmed: 11222100
Biophys J. 2014 Aug 19;107(4):912-23
pubmed: 25140426
J Biomol Struct Dyn. 2019 Feb;37(3):671-690
pubmed: 29388479
J Virol. 2005 Nov;79(21):13673-84
pubmed: 16227287
J Virol. 2013 Jun;87(11):6182-91
pubmed: 23536660
J Biol Chem. 2014 Jul 18;289(29):20067-77
pubmed: 24891509
J Gen Virol. 1997 Jul;78 ( Pt 7):1589-96
pubmed: 9225034
J Virol. 2010 May;84(9):4673-81
pubmed: 20181696
Cell Rep. 2018 Apr 10;23(2):596-607
pubmed: 29642015
J Virol. 2000 May;74(10):4634-44
pubmed: 10775599
Cell. 1991 Oct 4;67(1):117-30
pubmed: 1913813
J Virol. 2012 Feb;86(3):1522-30
pubmed: 22090133
Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19123-7
pubmed: 17146053
Biochim Biophys Acta. 2005 Dec 30;1746(3):260-73
pubmed: 15951036
J Virol. 2013 May;87(10):5621-8
pubmed: 23468509
mBio. 2014 May 13;5(3):e00070-14
pubmed: 24825008
PLoS One. 2014 Oct 08;9(10):e109510
pubmed: 25295515
J Gen Virol. 2016 Aug;97(8):1755-1764
pubmed: 27365089
Biophys J. 2019 Mar 5;116(5):893-909
pubmed: 30773293
J Virol. 2017 Oct 13;91(21):
pubmed: 28794042
J Biol Chem. 1999 Jan 22;274(4):2038-44
pubmed: 9890962
J Virol. 2006 Aug;80(16):8178-89
pubmed: 16873274
J Virol. 2013 Jan;87(1):345-53
pubmed: 23077315
J Biol Chem. 2004 Aug 20;279(34):35486-93
pubmed: 15123646
PLoS One. 2016 Nov 4;11(11):e0165421
pubmed: 27814373
Cell. 1992 Feb 7;68(3):533-44
pubmed: 1531449
J Exp Med. 2017 May 1;214(5):1239-1248
pubmed: 28396461
J Virol. 2008 Dec;82(23):11869-79
pubmed: 18815307
Nat Struct Biol. 1997 Mar;4(3):239-44
pubmed: 9164466
J Virol. 2017 Apr 13;91(9):
pubmed: 28202765
Virology. 2017 May;505:23-32
pubmed: 28219018
J Virol. 2012 Feb;86(3):1789-801
pubmed: 22114333
J Virol. 1996 Jan;70(1):241-7
pubmed: 8523532
J Proteome Res. 2008 Jan;7(1):40-4
pubmed: 18052118
J Virol Methods. 2011 Apr;173(1):1-6
pubmed: 21185869
Genome Biol. 2003;4(11):234
pubmed: 14611651
Genes Cells. 2001 Apr;6(4):375-88
pubmed: 11318879
Virology. 2001 Jan 20;279(2):439-46
pubmed: 11162800
J Virol. 2008 Oct;82(20):10059-70
pubmed: 18701586
Trends Microbiol. 2018 Jul;26(7):624-636
pubmed: 29373257
Virus Res. 2009 Aug;143(2):147-61
pubmed: 19481124
Nature. 2010 Feb 11;463(7282):813-7
pubmed: 20027183
J Virol. 2019 Jun 14;93(13):
pubmed: 30996098
J Virol. 1989 Sep;63(9):3586-94
pubmed: 2474671
Cell. 1992 May 15;69(4):577-8
pubmed: 1375129
Rev Med Virol. 2012 May;22(3):166-81
pubmed: 22113983
Adv Virus Res. 1954;2:59-79
pubmed: 13228257
PLoS Pathog. 2012;8(11):e1002993
pubmed: 23144613
J Gen Virol. 2007 Aug;88(Pt 8):2280-90
pubmed: 17622633
Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10685-90
pubmed: 20498070
Nat Commun. 2012 Jan 24;3:639
pubmed: 22273677